#United States #New York #Class Action #Inc. #Merck & Co. #Gardasil

Merck & Co. Investors: Important Class Action Notification

The Gross Law Firm has issued a critical notice to investors holding shares of Merck & Co., Inc. (NYSE: MRK). This notification concerns a class action lawsuit that may significantly impact shareholders who acquired MRK stocks between February 3, 2022, and February 3, 2025.

Background of the Allegations

At the heart of the lawsuit are allegations that Merck provided false or misleading information regarding projected revenues from its vaccine Gardasil. Initially, Merck had confidently projected sales of $11 billion by 2030. However, as per the complaint, the company later announced that it would halt shipments of Gardasil to China for at least part of 2025 due to lower-than-expected demand. The announcement, made on February 4, 2025, came as a shock to investors, resulting in a dramatic stock price decline of over 9% within a single day.

Timeline of Events

• - February 3, 2025: Merck's stock closed at $99.79 per share.
• - February 4, 2025: After the announcement regarding Gardasil, the stock plummeted to $90.74 per share.

The lawsuit is grounded in the belief that the inflated sales forecast and the subsequent drop in stock value constituted manipulation and provided grounds for investors to seek recovery for their losses.

Key Details for Shareholders

The Gross Law Firm is urging all eligible shareholders to act swiftly. The deadline for registering and seeking lead plaintiff status is April 14, 2025. However, registering does not require investors to assume lead plaintiff responsibilities; all shareholders may still participate in the recovery process.

To become part of the case, shareholders must complete the registration form available at Gross Law Firm Registration. Upon registration, participants will receive updates and monitoring related to the case's progress.

Next Steps

1. Register: Fill out the form to register as a shareholder who purchased MRK shares during the specified class period.
2. Stay Informed: Keep tabs on the lawsuit’s progress through the monitoring software provided to registered participants.
3. Consult Legal Counsel: It may be beneficial to review your options with a legal representative to understand your rights fully and any potential implications.

Why Choose the Gross Law Firm?

The Gross Law Firm is highly regarded for its expertise in dealing with class action lawsuits. They focus on shielding investors from fraudulent and unlawful corporate practices. Their commitment lies in ensuring companies uphold ethical practices, providing restitution for investors affected by misleading company statements or actions.

With a team of dedicated professionals, the Gross Law Firm aims to represent the interests of investors, mobilizing to hold companies accountable for their misconduct. The notice serves as a reminder of the importance of due diligence and vigilance in the investment space.

The firm encourages any shareholders with questions or who wish to discuss the lawsuit further to reach out directly:
- Address: The Gross Law Firm, 15 West 38th Street, 12th floor, New York, NY 10018
- Email: Email
- Phone: (646) 453-8903

In conclusion, investors should take this notification seriously, as participation in the class action could enable recovery for losses incurred due to the alleged misinformation regarding Merck's Gardasil revenue forecasts.

• ---